Phenotypic Characterization and Heterogeneity among Modern Clinical Isolates of Acinetobacter baumannii-Reference-Cited by-同舟云学术

Phenotypic Characterization and Heterogeneity among Modern Clinical Isolates of Acinetobacter baumannii

Published:2023-02-14 Issue:1 Volume:11 Page:
ISSN:2165-0497
Container-title:Microbiology Spectrum
language:en
Short-container-title:Microbiol Spectr

Author:

Valcek Adam¹²^ORCID,Philippe Chantal³,Whiteway Clémence¹²,Robino Etienne¹²,Nesporova Kristina¹²^ORCID,Bové Mona⁴,Coenye Tom⁴,De Pooter Tim⁵⁶,De Coster Wouter⁷⁸,Strazisar Mojca⁵⁶,Van der Henst Charles¹²^ORCID

Affiliation:

1. Microbial Resistance and Drug Discovery, VIB-VUB Center for Structural Biology, VIB, Flanders Institute for Biotechnology, Brussels, Belgium

2. Structural Biology Brussels, Vrije Universiteit Brussel (VUB), Brussels, Belgium

3. Research Unit in the Biology of Microorganisms (URBM), NARILIS, University of Namur (UNamur), Namur, Belgium

4. Laboratory of Pharmaceutical Microbiology, Ghent University, Ghent, Belgium

5. Neuromics Support Facility, VIB Center for Molecular Neurology, VIB, Antwerp, Belgium

6. Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium

7. Applied and Translational Neurogenomics Group, VIB Center for Molecular Neurology, VIB, Antwerp, Belgium

8. Applied and Translational Neurogenomics Group, Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium

Abstract

Acinetobacter baumannii is a bacterium prioritized by the CDC and WHO because of its increasing antibiotic resistance, leading to treatment failures. The hallmark of this pathogen is the high heterogeneity observed among isolates, due to a very dynamic genome.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Cell Biology,Microbiology (medical),Genetics,General Immunology and Microbiology,Ecology,Physiology

Link

https://journals.asm.org/doi/pdf/10.1128/spectrum.03061-22

Reference71 articles.

1. Defining and combating antibiotic resistance from One Health and Global Health perspectives

2. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology

3. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis

4. Antibiotic resistance threats in the United States, 2019

5. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Global challenges and microbial biofilms: Identification of priority questions in biofilm research, innovation and policy;Biofilm;2024-12

2. The unique Legionella longbeachae capsule favors intracellular replication and immune evasion;PLOS Pathogens;2024-09-11

3. Lipidomic analyses reveal distinctive variations in homeoviscous adaptation among clinical strains of Acinetobacter baumannii , providing insights from an environmental adaptation perspective;Microbiology Spectrum;2024-09-10

4. Characterization of the carbapenem-resistant Acinetobacter baumannii clinical reference isolate BAL062 (CC2:KL58:OCL1): resistance properties and capsular polysaccharide structure;mSystems;2024-09-10

5. A panel of genotypically and phenotypically diverse clinical Acinetobacter baumannii strains for novel antibiotic development;Microbiology Spectrum;2024-08-06